Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Medical implants: the inside story

16.01.2008
Patients suffering from conditions such as stroke, blindness, deafness, incontinence, glaucoma or hydrocephalus will be the first to benefit from a range of new technologies and implantable medical devices developed by a pioneering European consortium of researchers, surgeons and technology companies.

Half a century ago, Swedish scientists invented the first implantable heart pacemaker, demonstrating the potential of treating medical conditions by placing electronic devices within the human body. Now a consortium of 27 universities, research centres, hospitals, technology companies and manufacturers is developing new micro-technologies for implantable medical devices of the future.

The EU’s Healthy Aims project includes partners from seven EU countries, Switzerland and Israel, all of whom were already members of a medical devices industry association. “We started with a very strong group of people,” recalls Diana Hodgins of European Technology for Business Ltd, the project coordinator. “We looked at the clinical needs and the end manufacturers’ requirements and married those up to the technologies that we had available.”

In its four years, the project has pioneered three powered implants and three diagnostic devices.

Six products
A common consequence of a stroke is that patients lose control of an arm and are unable to release their grip. In functional electrical stimulation (FES), muscles are activated by signals from an implant. “Our stimulator extends the wrist, so the hand is in the right position, and then opens the fingers and thumb ready for an object to be grasped,” Hodgins explains.

“The first ones have been implanted and we’ve had some excellent results.” The technology is now being extended to tackle incontinence by helping patients control their bladder and bowel sphincter muscles.

A second product restores limited vision in certain types of blindness. A camera chip integrated into a pair of glasses transmits data to an array of electrodes inside the eyeball which stimulate retinal nerve cells. The image has 231 points which is a major achievement for patients with no sight at all. Clinical trials are already underway.

Similar technologies are being used in a cochlear implant to restore hearing. Compared to existing devices, the implant will improve voice recognition in noisy environments by having more stimulation sites and placing them in the inner cochlea, sending electrical impulses directly to the brain.

Yet another implant will measure the pressure inside the brain cavity, a crucial diagnostic for sufferers of hydrocephalus where an excess of fluid can damage the brain.

Three diagnostic tools are also emerging from the Healthy Aims project. The glaucoma sensor, a contact lens incorporating a ‘strain gauge’ to monitor the pressure within the eyeball, is already being trialled with patients. A catheter for measuring the pressure inside the bladder will help diagnose cases of incontinence. And an activity monitor, spun-off from the FES work, will keep track of a person’s physical activity over a period of time, in sport as well as in medicine.

All these products share a small number of core micro-technologies, developed within the project, that will give the European medical devices industry a toolkit of techniques for the future.

Healthy results
The first is wireless communication. All the implants and sensors transmit and receive data without any connecting wires. Although a single solution for all the devices has not proved practicable, the project has developed a technology (based on the ‘medical implants communications service’, or MICS, standard) that can transmit radio waves from an implant to a receiver worn on the body.

“While it wasn’t suitable for all the applications, it’s the ideal solution for FES,” says Hodgins. “We now have a working MICS system that can be sold anywhere in the world.”

The partners have developed arrays of tiny microelectrodes to stimulate nerves or muscles and the connectors to join them to supporting electronics. “Platinum electrodes are the most common for implantable devices and the most difficult to make and join to in an automated process. We’ve learned a great deal and we are now sharing that with other projects,” says Hodgins.

Implants have to last for the life of the patient. That means that they must be completely enclosed by materials that will not degrade by long exposure to body fluids. The team has come up with two new materials, a modified silicone and diamond-like coating (DLC), both of which look very promising.

Finally, implants need a source of power. At present, the only makers of implantable batteries are in the USA and they do not sell their technology to competitors. Now, thanks to Healthy Aims, two new European prototypes are moving towards clinical trials: a rechargeable battery, suitable for powering the FES and cochlear implants, and a fuel cell powered by the body’s own glucose which could run a heart pacemaker for ten years.

With several products only two to four years from certification, and the MICS system and activity monitor even sooner, the project has given a huge boost not just to the partners but to the European medical devices sector as a whole.

“We’ve actually surprised the Americans,” says Hodgins who regularly receives invitations to present the work of the consortium in international conferences and journals.

“They’re coming to us and saying ‘please tell us what you’re up to’. On all of these things, we’re leading the world. People will talk about this project for a long time to come.”

Christian Nielsen | alfa
Further information:
http://cordis.europa.eu/ictresults/index.cfm/section/news/tpl/article/BrowsingType/Features/ID/89278

More articles from Medical Engineering:

nachricht Novel PET tracer identifies most bacterial infections
06.10.2017 | Society of Nuclear Medicine and Molecular Imaging

nachricht Teleoperating robots with virtual reality
05.10.2017 | Massachusetts Institute of Technology, CSAIL

All articles from Medical Engineering >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Neutron star merger directly observed for the first time

University of Maryland researchers contribute to historic detection of gravitational waves and light created by event

On August 17, 2017, at 12:41:04 UTC, scientists made the first direct observation of a merger between two neutron stars--the dense, collapsed cores that remain...

Im Focus: Breaking: the first light from two neutron stars merging

Seven new papers describe the first-ever detection of light from a gravitational wave source. The event, caused by two neutron stars colliding and merging together, was dubbed GW170817 because it sent ripples through space-time that reached Earth on 2017 August 17. Around the world, hundreds of excited astronomers mobilized quickly and were able to observe the event using numerous telescopes, providing a wealth of new data.

Previous detections of gravitational waves have all involved the merger of two black holes, a feat that won the 2017 Nobel Prize in Physics earlier this month....

Im Focus: Smart sensors for efficient processes

Material defects in end products can quickly result in failures in many areas of industry, and have a massive impact on the safe use of their products. This is why, in the field of quality assurance, intelligent, nondestructive sensor systems play a key role. They allow testing components and parts in a rapid and cost-efficient manner without destroying the actual product or changing its surface. Experts from the Fraunhofer IZFP in Saarbrücken will be presenting two exhibits at the Blechexpo in Stuttgart from 7–10 November 2017 that allow fast, reliable, and automated characterization of materials and detection of defects (Hall 5, Booth 5306).

When quality testing uses time-consuming destructive test methods, it can result in enormous costs due to damaging or destroying the products. And given that...

Im Focus: Cold molecules on collision course

Using a new cooling technique MPQ scientists succeed at observing collisions in a dense beam of cold and slow dipolar molecules.

How do chemical reactions proceed at extremely low temperatures? The answer requires the investigation of molecular samples that are cold, dense, and slow at...

Im Focus: Shrinking the proton again!

Scientists from the Max Planck Institute of Quantum Optics, using high precision laser spectroscopy of atomic hydrogen, confirm the surprisingly small value of the proton radius determined from muonic hydrogen.

It was one of the breakthroughs of the year 2010: Laser spectroscopy of muonic hydrogen resulted in a value for the proton charge radius that was significantly...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ASEAN Member States discuss the future role of renewable energy

17.10.2017 | Event News

World Health Summit 2017: International experts set the course for the future of Global Health

10.10.2017 | Event News

Climate Engineering Conference 2017 Opens in Berlin

10.10.2017 | Event News

 
Latest News

Terahertz spectroscopy goes nano

20.10.2017 | Information Technology

Strange but true: Turning a material upside down can sometimes make it softer

20.10.2017 | Materials Sciences

NRL clarifies valley polarization for electronic and optoelectronic technologies

20.10.2017 | Interdisciplinary Research

VideoLinks
B2B-VideoLinks
More VideoLinks >>>